(NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) ...

Skvarka, a director at Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), has purchased 60,000 shares of the company's common stock, according to a recent SEC filing. This insider purchase comes as ...

Luke Walker, a director at Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently acquired additional shares of the company's common stock. According to a recent SEC filing, Walker purchased 14,200 ...

NetraMark Holdings Inc. (the "Company" or "NetraMark")    a generative AI software leader in clinical trial analytics, is pleased to highlight recent corporate advancements; including a key leadership ...

This was the stock's third consecutive day of losses.

LLY is reporting earnings tomorrow and the options market predicts major moves. PFP system shows bullish positioning and ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...

Nuvectis Pharma (NVCT) announced that it has commenced an underwritten public offering of its common stock. All of the shares to be sold in the ...

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.